带状疱疹药物市场(主要地区、市场参与者、规模和份额)-到 2031 年的预测

  • Report Code : TIPRE00023676
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

市场概览 带状疱疹,也称为带状疱疹,是一种由水痘带状疱疹病毒引起的急性病毒感染,与引起水痘的病毒类似。水痘是由水痘带状疱疹病毒初次感染引起的;水痘治愈后,病毒在神经细胞中保持不活跃状态,并反应性地传播到神经末梢,产生水泡。它会导致皮肤出现严重皮疹,并伴有发烧、头痛、疲劳和肌肉无力。这种感染可影响任何免疫系统较弱的人,主要流行于 50 岁以上的老年人。该病可以通过口服药物、外用药物和疫苗来治愈。 市场范围 《到2031年全球带状疱疹药物市场分析》是对医疗保健行业的专业深入研究,特别关注全球市场趋势分析。该报告旨在概述带状疱疹药物市场,并按药物、疫苗、给药途径、分销渠道、最终用户和地理位置进行详细的市场细分。该报告提供了主要带状疱疹药物市场参与者的市场状况的关键统计数据,并提供了市场的主要趋势和机会。 市场细分
    - 根据药物,全球带状疱疹药物市场分为抗病毒药、抗炎药、镇痛药、抗惊厥药、皮质类固醇、三环类抗抑郁药、抗组胺药等。 - 根据疫苗,市场分为 zostavax、shingrix 等。 - 根据给药途径,市场分为口服、局部、静脉注射等。 - 根据分销渠道,市场分为网上药店、零售商和其他。 - 根据最终用户,市场分为医院、家庭护理、专科诊所等。
市场动态 驱动因素:
    - 带状疱疹患病率上升、癌症和艾滋病患者发病率上升以及老年人口增加推动了疱疹的发生带状疱疹药物市场的增长。 - 疫苗的增加和医疗保健支出的增加推动了市场的增长。 - 技术发展和医疗保健基础设施的改善推动市场增长。
限制:
    - 抗体成本高。
该报告提供了该行业的详细概述,包括定性和定量信息。它提供了基于各个细分市场的全球市场的概述和预测。它还提供了 2021 年至 2031 年五个主要地区的市场规模和预测估计,即:北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美洲。每个地区的带状疱疹药物市场随后按各自的国家和细分市场进行细分。该报告涵盖了全球18个国家以及该地区当前趋势和机遇的分析和预测。报告从需求和供给两个方面分析了影响市场的因素,并进一步评估了预测期内影响市场的市场动态,即驱动因素、限制因素、机会和未来趋势。该报告还为所有五个地区提供了详尽的 PEST 分析,即:在评估了北美、欧洲、亚太地区、中东和非洲和南美洲影响带状疱疹药物市场的政治、经济、社会和技术因素后。 COVID-19 对带状疱疹药物市场的影响COVID-19 于 2021 年 12 月首次在中国武汉爆发,此后在全球范围内快速传播。从确诊病例和死亡人数来看,美国、印度、巴西、俄罗斯、法国、英国、土耳其、意大利和西班牙是受影响最严重的国家。冠状病毒大流行的日益流行和新冠疫苗的快速推出导致带状疱疹疫苗销量下降,从而影响了带状疱疹药物市场。由于公共卫生系统优先关注大流行疫苗接种,导致药物处方受到严重干扰。但由于基础需求旺盛,随着厂商的限制措施的解除以及新政策的出台,预计未来市场将出现增长。 市场参与者 该报告涵盖了带状疱疹药物市场的主要发展,包括有机和无机增长策略。许多公司都专注于有机增长战略,例如产品发布、产品批准以及专利和活动等其他战略。市场上出现的无机增长战略活动包括收购、伙伴关系和合作。这些活动为市场参与者扩大业务和客户群铺平了道路。随着全球市场对带状疱疹药物的需求不断增长,预计带状疱疹药物市场的市场参与者未来将拥有利润丰厚的增长机会。该报告还包括带状疱疹药物市场主要公司的概况及其 SWOT 分析和市场策略。此外,该报告重点关注领先的行业参与者,提供公司简介、所提供的组件和服务、过去三年的财务信息、过去五年的关键发展等信息。
    - 辉瑞公司 - 雅培公司 - 诺华公司 - 默克公司 - 葛兰素史克公司 - 罗氏公司 - 百时美施贵宝公司 - 安斯泰来制药公司 - GeneOne Life Science - Camber Pharmaceuticals Insight Partner 的专业研究和分析团队由经验丰富的专业人士组成,拥有先进的统计专业知识,并在现有研究中提供各种定制选项。
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment accounts for highest revenue by drug in 2023?

Anti-Viral Agents segment, by drug, dominated the market in 2023.

Which are some of the players operating in the Herpes Zoster Drug market?

Players operating in the market are Pfizer Inc, Abbott, Novartis AG, Merck & Co., Inc., GlaxoSmithKline plc, F. Hoffmann,La Roche Ltd, Bristol, Myers Squibb Company, Astellas Pharma Inc., GeneOne Life Science, Camber Pharmaceuticals

Which region dominated the Herpes Zoster Drug market in 2023?

North America region dominated the Herpes Zoster Drug market in 2023.

What are the factor that act as a opportunity for market growth?

Growth in Geriatric Population act as a opportunity for growth of the market in forecast period.

What is the expected CAGR of the Herpes Zoster Drug Market?

The Herpes Zoster Drug Market is estimated to witness a CAGR of 6.9% from 2023 to 2031

What are the driving factors impacting the Herpes Zoster Drug market?

The major factors driving the Herpes Zoster Drug market are:

1. Rising Incidence of Herpes Zoster

2. Advancement of Vaccine Development

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

- Pfizer Inc
- Abbott
- Novartis AG
- Merck & Co., Inc.
- GlaxoSmithKline plc
- F. Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Company
- Astellas Pharma Inc.
- GeneOne Life Science
- Camber Pharmaceuticals

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.